Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular involvements, including ventricular functions. The aim of our study was to evaluate the right ventricular functions of mild severity COVID-19 patients 3 months after, and compare them to the right ventricular functions of healthy volunteers. For this single-center study, data from 105 patients who were treated for mild severity COVID-19 between September 15, 2020 and December 31, 2020 were collected. 105 age and sex matched healthy subjects were included in the study. Right ventricular (RV) functions were evaluated using conventional two-dimensional (2D) echocardiography and 2D speckle-tracking echocardiography (STE) for all patients. 2D-E parameters indicating RV functions were compared between the two groups. RV diamaters, systolic pulmonary artery pressure (sPAP) and RV myocardial performance index (RV MPI) were significantly higher in the COVID-19 patients compared to control group (p < 0.05). Tricuspid annular plane systolic motion (TAPSE), right ventricular fractional area change (RVFAC) and RV S' were significantly lower in the COVID-19 group compared to control group (p < 0.05). RV global longitudinal strain (RV-GLS) (− 19.6 ± 5.2 vs. − 15.1 ± 3.4, p < 0.001) and RV free wall longitudinal strain RV-FWLS (− 19.6 ± 5.2 vs. − 17.2 ± 4.4, p < 0.001) values were significantly lower in the COVID-19 group than the control group. There was a significant negative correlation between RV-FWLS, RV-GLS and C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), d-dimer, ferritin, platelet to lymphocyte ratio (PLR) in patients with mild severity COVID-19. This results suggested that RV-GLS and RV-FWLS decreased in the long term (third month) follow-up of patients treated for mild severity COVID-19 disease. Subclinical RV dysfunction may be observed in patients after mild severity COVID-19.

Amaç: COVID-19 hastalığının, sol ventrikül fonksiyonu üzerindeki uzun dönem etkilerini speckle tracking ekokardiyografi kullanarak, değerlendirmeyi amaçladık. Yöntemler: Çalışmamıza 15 Ağustos 2020 - 01 Eylül 2020 tarihleri arasında merkezimizde COVID-19 hastalığı tanısı konan ve hastaneye yatmayan 96 hasta ile yaş ve cinsiyet olarak uyumlu, 96 kontrol olgusu dahil edildi. Bulgular: Ortalama takip süresi 137 ± 7 gündü. Beyaz kan hücresi, nötrofil ve lenfosit, COVID-19 grubunda önemli ölçüde daha düşüktü ve C-reaktif protein (CRP) ve nötrofil lenfosit oranı (NLR) önemli ölçüde daha yüksekti. (sırasıyla 6,6 ± 2,8 - 24,4 ± 21,8, p

Bu çalışmada üçüncü basamak bir hastanenin kardiyoloji polikliniğine başvuran hastalarda, sosyo-demografik ve hastalığa ilişkin özellikler ile sağlıklı yaşam biçimi davranışlarına etki eden faktörlerin değerlendirilmesi amaçlanmıştır. GEREÇ VE YÖNTEM: Tanımlayıcı tipte planlanan bu araştırma Samsun Eğitim ve Araştırma Hastanesi Kardiyoloji Polikliniği' ne başvuran 141 gönüllü hasta ile yapıldı. Hastalara araştırmacılar tarafından düzenlenen anket formu ve Sağlıklı Yaşam Biçimi Davranışları Ölçeği II (SYBDÖ-II) uygulandı. Verilerin istatistiksel değerlendirilmesinde parametrik ve nonparametrik testler kullanıldı. Tüm testler için istatistik anlamlılık düzeyi p<0,05 olarak kabul edildi. BULGULAR: Hastaların yaş ortalaması 49,1±1,54 yıl olup, %51,8'i erkek; %48,9'u en az lise mezunuydu. Katılımcıların ölçek toplam puan ortalamasının 123,8±21,3 olduğu belirlendi. SYBDÖ-II alt ölçeklerinden bazılarının 18-35 yaş arasında olanlarda, bekârlarda, KVH tanı süresi 5 yıl ve üstü olanlarda, ek hastalığı olmayanlarda, alkol kullanmayanlarda ve sigarayı bırakmış olanlarda istatistiksel olarak daha yüksek düzeyde görüldüğü belirlendi (p<0.05). SONUÇ: Kardiyovasküler hastalığı olan bazı bireylerde sağlıklı yaşam biçimi davranışlarına sahip olmakla birlikte, evli, yaşlı, ek hastalığı olan veya yeni tanı alan KVH hastalarının SYBDÖ-II puanlarının bazı alanlarda yetersiz olduğu belirlendi. Bu özellikler dikkate alınarak KVH hastalarına yönelik hazırlanacak olan eğitim ve rehabilitasyon programlarının, onların sağlıklı yaşam biçimi davranışları geliştirmeleri ve sürdürmelerine katkı sağlayacağını düşünüyoruz.

Background: We aimed to evaluate the relationship between hospital admissions and hospitalizations from respiratory system diseases, cardiovascular diseases, neurological and psychiatric diseases with the air pollution in the central districts of Samsun, 2018. The second aim of the study was to calculate the total number of deaths that can be attributed to air pollution with the AIR Q + program. Material and Methods: The study is an ecological type. Daily PM10 data were collected as the determinant of air pollution. The records of all applications and hospitalizations that received any of the ICD-10 diagnostic codes I00-99,J00-99,F00-99,G00-99 were included in the study. Correlation and regression analyzes were conducted to explain the relationships between hospital admissions, hospitalizations and PM10 and meteorological parameters. Results: The annual average of PM10 was found to be 50.4±19.3 μg/m3. There were positive and statistically significant correlations between the daily number of admissions of all diseases evaluated with PM10. Positive and statistically significant correlations were found between hospitalizations for only respiratory and cardiovascular system diseases with PM10. Admissions from respiratory system diseases (3%), cardiovascular (2%), neurological (1%) and psychiatric diseases (1%) and hospitalizations from respiratory diseases (%2) increased by for every 10 μg / m3 increase in PM10 level. The annual average of PM2.5 was found to be 31.8 μg/m3 using the AIR Q + program. The number of natural deaths that can be attributed to air pollution in 2018 was 835 (12.3%), and the estimated number of deaths attributable to 100,000 people at risk was 111.8 (RR: 1.14). Conclusion: Hospital admissions and hospitalizations are increasing due to air pollution. Many deaths and adverse health effects can be prevented by reducing the air pollution that increases especially in the winter period to the determined limit values.

Purpose: We aimed to evaluate long term effects of COVID-19 disease on left ventricular function using speckle tracking echocardiography. Methods: In our study, 96 non-hospitalized patients who were diagnosed with COVID-19 disease in our center between 15 August 2020 and 01 September 2020 and 96 age and gender matched control subjects were included.Results:The mean follow up duration was 137 ± 7 days. White blood cell, neutrophile and lymphocyte were significantly lower and C-reactive protein (CRP) and neutrophil to lymphocyte ratio (NLR) were significantly higher in the COVID-19 group. (6.6 ± 2.8 vs. 24.4 ± 21.8, p <0.001 and 4.1 ± 2.5 vs. 7.1 ± 4, p <0.001, respectively). LV-GLS and LV-GCS were significantly lower in the COVID-19 group. (-20.1 ± 3.1 vs -15.9 ± 2, p <0.001 and -29.3 ± 2.1 vs -26.3 ± 2.1, p <0.001, respectively). LV-GLS and LV-GCS were found to be negatively correlated with CRP (rs = -0.515, p <0.001 and rs = 0.-466, p <0.001, respectively) and NLR (rs = -0.494, p <0.001 and rs = -434, p <0.001, respectively). Conclusion: Deteriorating effects of COVID-19 disease on both LV-GCS and LV-GLS can be seen even in the short term. These detrimental effects seem to be associated with CRP levels and NLR measured in the course of active infection.